SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Oct-24 4:10 PM View: | Neumora Therapeutics, Inc. (NMRA) | 10-Oct-24 | Sale (Planned) | 8,260 | $15.09 | $124,603.00 | (3%) 322.97K to 314.71K | |
11-Oct-24 4:10 PM View: | Neumora Therapeutics, Inc. (NMRA) | 09-Oct-24 | Sale (Planned) | 5,563 | $15.01 | $83,507.30 | (2%) 328.53K to 322.97K | |
19-Sep-24 4:35 PM View: | Neumora Therapeutics, Inc. (NMRA) | 18-Sep-24 | Sale (Planned) | 10,676 | $12.09 | $129,091.00 | (3%) 339.2K to 328.53K | |
19-Sep-24 4:35 PM View: | Neumora Therapeutics, Inc. (NMRA) | 17-Sep-24 | Sale (Planned) | 30,788 | $11.81 | $363,736.00 | (8%) 369.99K to 339.2K | |
16-Sep-24 4:05 PM View: | Neumora Therapeutics, Inc. (NMRA) | 12-Sep-24 | Sale (Planned) | 32,948 | $11.43 | $376,665.00 | (8%) 402.94K to 369.99K | |
16-Feb-24 4:13 PM View: | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 50,000 | -- | -- | 14% 352.94K to 402.94K | |
18-Sep-23 5:58 PM View: | Neumora Therapeutics, Inc. (NMRA) | 14-Sep-23 | Grant | 352,941 | -- | -- | 100% 0 to 352.94K |